45 related articles for article (PubMed ID: 8021724)
1. Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.
López-Guillermo A; Montserrat E; Bosch F; Terol MJ; Campo E; Rozman C
J Clin Oncol; 1994 Jul; 12(7):1343-8. PubMed ID: 8021724
[TBL] [Abstract][Full Text] [Related]
2. A novel prognostic index for sporadic Burkitt lymphoma in adult patients: a real-word multicenter study.
Chen MT; Pan F; Chen YC; Zhang W; Lv HJ; Wang Z; Hong HM; Fang XJ; Wang YW; Pan T; Zou LQ; Guo HQ; Xie K; Chen LM; Li XQ; Yao YY; Chen ZG; Weng HW; Li XD; Shen YY; Zhou H; Xue HW; Zhang HL; Huang H; Lin TY
BMC Cancer; 2022 Jan; 22(1):45. PubMed ID: 34996395
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial.
Bruna R; Benedetti F; Boccomini C; Patti C; Barbui AM; Pulsoni A; Musso M; Liberati AM; Gini G; Castellino C; Rossini F; Ciceri F; Rota-Scalabrini D; Stelitano C; Di Raimondo F; Tucci A; Devizzi L; Zoli V; Zallio F; Narni F; Dondi A; Parvis G; Semenzato G; Lanza F; Perrone T; Angrilli F; Billio A; Gueli A; Mantoan B; Rambaldi A; Gianni AM; Corradini P; Passera R; Ladetto M; Tarella C
Haematologica; 2019 Nov; 104(11):2241-2248. PubMed ID: 31666344
[TBL] [Abstract][Full Text] [Related]
4. Follicular Lymphoma: Diagnostic and Prognostic Considerations in Initial Treatment Approach.
Boughan KM; Caimi PF
Curr Oncol Rep; 2019 May; 21(7):63. PubMed ID: 31119485
[TBL] [Abstract][Full Text] [Related]
5. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
Bachy E; Maurer MJ; Habermann TM; Gelas-Dore B; Maucort-Boulch D; Estell JA; Van den Neste E; Bouabdallah R; Gyan E; Feldman AL; Bargay J; Delmer A; Slager SL; Gomes da Silva M; Fitoussi O; Belada D; Maisonneuve H; Intragumtornchai T; Ansell SM; Lamy T; Dartigues P; Link BK; Seymour JF; Cerhan JR; Salles G
Blood; 2018 Jul; 132(1):49-58. PubMed ID: 29666118
[TBL] [Abstract][Full Text] [Related]
6. Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial.
Seo J; Kim WS; Kim JS; Kim SJ; Lee JH; Hong JS; Lee GW; Oh SY; Lee JH; Yoon DH; Lee WS; Kim HJ; Kwak JY; Kang HJ; Jo JC; Park Y; Lee HS; Kim HJ; Suh C
Blood Res; 2017 Sep; 52(3):200-206. PubMed ID: 29043235
[TBL] [Abstract][Full Text] [Related]
7. Unmet needs in the first-line treatment of follicular lymphoma.
Casulo C; Nastoupil L; Fowler NH; Friedberg JW; Flowers CR
Ann Oncol; 2017 Sep; 28(9):2094-2106. PubMed ID: 28430865
[TBL] [Abstract][Full Text] [Related]
8. Prognostic assessment in patients with indolent B-cell lymphomas.
Arcaini L; Rattotti S; Gotti M; Luminari S
ScientificWorldJournal; 2012; 2012():107892. PubMed ID: 22919288
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of biochemical markers in African Burkitt's lymphoma.
Arthur FK; Owusu L; Yeboah FA; Rettig T; Osei-Akoto A
Clin Transl Oncol; 2011 Oct; 13(10):731-6. PubMed ID: 21975335
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas.
Shah N; Cabanillas F; McIntyre B; Feng L; McLaughlin P; Rodriguez MA; Romaguera J; Younes A; Hagemeister FB; Kwak L; Fayad L
Leuk Lymphoma; 2012 Jan; 53(1):50-6. PubMed ID: 21895545
[TBL] [Abstract][Full Text] [Related]
11. Non-gastric marginal zone B-cell lymphoma in Korea: clinical features, treatment, and prognostic factors.
Oh SY; Suh C
Korean J Intern Med; 2010 Sep; 25(3):227-36. PubMed ID: 20830217
[TBL] [Abstract][Full Text] [Related]
12. Follicular lymphoma prognostic factors in the modern era: what is clinically meaningful?
Solal-Céligny P; Cahu X; Cartron G
Int J Hematol; 2010 Sep; 92(2):246-54. PubMed ID: 20803352
[TBL] [Abstract][Full Text] [Related]
13. Do recent reports of prolonged survival in patients with follicular lymphoma suggest that deferral of therapy is no longer justifiable?
Link BK
Curr Hematol Malig Rep; 2007 Oct; 2(4):219-24. PubMed ID: 20425373
[TBL] [Abstract][Full Text] [Related]
14. Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma.
Ai WZ; Tibshirani R; Taidi B; Czerwinski D; Levy R
Blood; 2009 Jun; 113(23):5743-6. PubMed ID: 19346494
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of prognostic indices in patients with follicular lymphomas.
Radojkovic M; Ristic S; Colovic M; Mihaljevic B; Cemerikic-Martinovic V
Med Oncol; 2006; 23(4):533-42. PubMed ID: 17303912
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular prognostic factors in follicular lymphoma.
Davies AJ
Curr Oncol Rep; 2006 Sep; 8(5):359-67. PubMed ID: 16901397
[TBL] [Abstract][Full Text] [Related]
17. Rituximab (Mabthera, Rituxan) in patients with recurrent indolent lymphoma: evaluation of safety and efficacy in a multicenter study.
Walewski J; Kraszewska E; Mioduszewska O; Romejko-Jarosińska J; Hellmann A; Czyz J; Hołowiecki J; Kopera M; Grosicki S; Komarnicki M; Rumianowski L; Kuliczkowski K; Wróbel T; Dwilewicz-Trojaczek J; Robak T; Warzocha K; Załuski J; Wójcik E; Dmoszyńska A; Walter-Croneck A;
Med Oncol; 2001; 18(2):141-8. PubMed ID: 11778760
[TBL] [Abstract][Full Text] [Related]
18. Re-treatment of relapsed indolent B-cell lymphoma with rituximab.
Igarashi T; Ohtsu T; Fujii H; Sasaki Y; Morishima Y; Ogura M; Kagami Y; Kinoshita T; Kasai M; Kiyama Y; Kobayashi Y; Tobinai K;
Int J Hematol; 2001 Feb; 73(2):213-21. PubMed ID: 11372734
[TBL] [Abstract][Full Text] [Related]
19. Assessment of prognostic factors in follicular lymphoma patients.
Kondo E; Ogura M; Kagami Y; Taji H; Miura K; Takeuchi T; Maeda S; Asakura S; Suzuki R; Nakamura S; Morishima Y
Int J Hematol; 2001 Apr; 73(3):363-8. PubMed ID: 11345204
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic hematopoietic transplantation for chronic lymphocytic leukemia and lymphoma: potential for nonablative preparative regimens.
Champlin R; van Besien K ; Giralt S; Khouri I
Curr Oncol Rep; 2000 Mar; 2(2):182-91. PubMed ID: 11122842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
